Our CEO, Dr Tom Congdon, has been featured in two insightful interviews with BioTechniques and Technology Networks to discuss how CryoLogyx is revolutionizing cell-based assays by mimicking natural cryoprotectants, making cell culture protocols simpler as well as Tom’s vision for the future of lab automation.

Technology Networks

Our CEO highlighted innovative cryopreservation technology at SLAS Europe 2024, winning a New Product Award. These advanced cryoprotectants mimic natural antifreeze proteins, improving the preservation and functionality of cells in drug discovery.

Read full article here.

BioTechniques

In BioTechniques, our CEO discussed how our synthetic cryoprotectants enhance cell viability and drug screening efficiency by imitating natural antifreeze mechanisms.

Read full article here.